Stock Price & Analysis

Based on the recent data and analysis, here's a concise assessment of OHI's current position:

Technical Analysis The stock recently crossed below its critical moving average, with current price at $36.87 showing weakness in the near-term momentum. RSI at 44.08 indicates neutral territory but leaning towards oversold conditions.

Recent Performance & Fundamentals OHI has experienced a notable decline, with a -2.77% drop in the last regular market session. The company recently provided 2025 AFFO guidance of $2.90-$2.98 per share, which was slightly below consensus of $3.02.

Analyst Consensus Recent analyst actions show mixed sentiment:

• JMP Securities maintained Hold rating (Feb 7, 2025)
• BMO Capital upgraded to Buy with $45 target (Dec 2024)
• Mizuho maintained Hold with $37 target

Recommendation Based on current technical weakness and mixed analyst sentiment, selling OHI at current levels appears prudent. The stock is showing bearish momentum after breaking below key support levels, and guidance slightly below expectations suggests limited near-term catalysts for upward movement.

Based on the provided data and recent analyst reports, here's the price prediction for OHI stock in 2025:

Omega Healthcare (OHI) is projected to reach $40-42 by end of 2025, representing a potential upside of 8-14% from current price of $36.87. The prediction is supported by management's 2025 FFO guidance of $2.90-$2.98 per share and Berenberg Bank's $45 price target.

The bullish case is driven by strong Q4 2024 performance with $279 million revenue, successful deployment of $1.1 billion in capital across 36 transactions, and reduced leverage to 3.96 times net funded debt to EBITDA - lowest in a decade.

However, analysts have expressed concerns over labor challenges and regulatory uncertainties that could impact the stock's performance in 2025. Recent analyst actions show mixed sentiment with JMP Securities maintaining Hold rating while Berenberg Bank maintains Buy rating with $45 target.

The S1 support level for OHI Stock is $36.27 ,The R1 resistant level for OHI Stock is $38.88.

As of the end of day on 2025-02-11, the price of OHI Stock was $36.87.

The target price for OHI Stock according to analyst rating is 41.86, with the highest price target at 45.00 and the lowest at 38.00. Analysts have a Hold rating on OHI Stock overall.

The market cap of OHI is $10.3B.

Based on recent valuation metrics and market data, OHI appears fairly valued. The stock's P/E ratio of 25.19x in Q4 2024 is slightly below its recent peak of 28.46x in Q1 2024, suggesting improved valuation. Recent analyst coverage shows mixed sentiment with BMO Capital upgrading to Buy with a $45 price target (+15.83% upside), while JMP Securities and Mizuho maintain Hold ratings [1,2]. The company's strong Q4 2024 performance with FAD at $0.70 per share and 2025 AFFO guidance of $2.90-$2.98 demonstrates stable operational metrics. The current dividend yield of 5.64% remains attractive for the healthcare REIT sector, though it has decreased from 6.74% in Q1 2024.

Omega Healthcare Investors, Inc. is a real estate investment trust (REIT). The Company operates through a single segment, which invests in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs). Its core portfolio consists of its long-term leases and real estate loans with healthcare operating companies and affiliates. In addition, the Company makes loans to operators and/or their principals. The Company's portfolio of real estate investments includes over 891 healthcare facilities, located in 42 states and the United Kingdom that are operated by 74 third-party operators.

Based on the provided data and analysis, here is the price prediction for OHI stock by 2030:

Omega Healthcare Investors (OHI) stock is projected to reach $52-55 by 2030, driven by favorable demographic trends in healthcare real estate and the company's strong market position in skilled nursing facilities. The company's robust investment pipeline and strategic acquisitions, particularly in the UK market which accounted for 68% of 2024's investments, support this growth trajectory. The current technical indicators showing RSI at 44.08 and negative MACD of -0.12 suggest a near-term consolidation phase, but the long-term fundamentals remain solid with steady dividend yields and improving operator performance metrics.

OHI has a total of 57 employees.